ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Procedure: Education

Study type: Observational

Funder types: Industry

Identifiers

NCT01388166

205.483

Details and patient eligibility

About

The objective of this observational study is to collect and evaluate data on medication adherence of patients on maintenance COPD therapy with long-acting anticholinergic (e.g. Spiriva® delivered by HandiHaler® or Respimat®) using the MMAS-8 questionnaire.

Full description

Purpose:

Enrollment: 1,253 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female ambulatory outpatients being seen in a participating physicians office for routine care,
• Patients with a clinical diagnosis of COPD and already being treated with the maintenance therapy with long-acting anticholinergic (Tiotropium (Spiriva® HandiHaler® or Respimat®) at least 1 month and within product label
• Patient fluent in language of questionnaire and having the cognitive and functional abilities required to fill in the questionnaire alone

Exclusion criteria

• Uncooperative patients as judged by the physician
• Patients with any conditions excluded as per Country specific package insert
• Patients currently enrolled in any clinical trial which requires a change in medication for their respiratory problems.

Trial design

1,253 participants in 1 patient group

Patients with COPD

Treatment:

Procedure: Education